Pharmaceuticals Inc Isis serves as Executive at Regulus Therapeutics Inc., where they oversee executive responsibilities. Since joining the company, Pharmaceuticals Inc Isis has executed 61 insider transactions totaling $31.1M, demonstrating a bearish approach to their equity position. Their most recent transaction on Jul 30, 2014 involved selling 1,000 shares valued at $6.6K.
Pharmaceuticals Inc Isis currently holds 5,173,172 shares of Regulus Therapeutics Inc. (RGLS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Pharmaceuticals Inc Isis has been a net seller of RGLS stock. They have purchased $3.0M and sold $28.1M worth of shares.
Pharmaceuticals Inc Isis's most recent insider trade was on Jul 30, 2014, when they sold 1,000 shares at $6.60 per share.
Get notified when new Form 4 filings are submitted
| $6.80 |
| Discretionary |
| Jul 17, 2014 | "RGLS" | $32.9K | Sale | 5,000 | $6.58 | Discretionary |
| Jul 16, 2014 | "RGLS" | $23.1K | Sale | 3,500 | $6.59 | Discretionary |
| Jul 11, 2014 | "RGLS" | $11.3K | Sale | 1,750 | $6.48 | Discretionary |
| Jul 10, 2014 | "RGLS" | $30.1K | Sale | 4,500 | $6.69 | Discretionary |
| Jul 9, 2014 | "RGLS" | $12.7K | Sale | 1,800 | $7.08 | Discretionary |
| Jul 3, 2014 | "RGLS" | $9.7K | Sale | 1,200 | $8.07 | Discretionary |
| Jul 2, 2014 | "RGLS" | $25.0K | Sale | 3,100 | $8.07 | Discretionary |
| Oct 10, 2012 | RGLS | $0 | Conversion | 6,299,500 | $N/A | Discretionary |
| Oct 10, 2012 | RGLS | $3.0M | Purchase | 750,000 | $4.00 | Discretionary |